Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study.

Autor: Aguirre C; Neurology Department, Hospital Universitario de La Princesa, Calle de Diego de León, 62, 28006, Madrid, Spain. claraguih@hotmail.com., Alonso-Torres A; Neurology Department, Hospital Regional de Málaga, Málaga, Spain., Agüera E; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Hospital Universitario Reina Sofía, University of Cordoba, Córdoba, Spain., García-Domínguez JM; Neurology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Montero-Escribano P; Neurology Department, Hospital Clínico San Carlos, IdISSC, Madrid, Spain., González-Quintanilla V; Neurology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Costa-Frossard L; Neurology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Oreja-Guevara C; Neurology Department, Hospital Clínico San Carlos, IdISSC, Madrid, Spain., Reyes-Garrido V; Neurology Department, Hospital Regional de Málaga, Málaga, Spain., Caminero-Rodríguez AB; Neurology Department, Complejo Asistencial de Ávila, Ávila, Spain., Riancho J; Neurology Department, Hospital General de Sierrallana, IDIVAL, CIBERNED, Dpto Medicina y Psiquiatría Universidad de Cantabria, Torrelavega, Spain., Sánchez O; Neurology Department, Hospital General Universitario Nuestra Señora del Prado, Talavera de la Reina, Spain., Forero L; Neurology Department, Hospital Puerta del Mar, Cádiz, Spain., Pérez-Parra F; Neurology Department, Hospital del Henares, Madrid, Spain., Ares-Luque A; Neurology Department, Complejo Asistencial Universitario de León, León, Spain., Téllez N; Neurology Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Arzalluz-Luque J; Neurology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain., Iglesias F; Neurology Department, Hospital Universitario de Burgos, Burgos, Spain., Casado-Ruiz V; Neurology Department, Hospital de Mataró, Mataró, Spain., Castellano-Vicente AJ; Neurology Department, Hospital General de Valdepeñas, Ciudad Real, Spain., Borrega L; Neurology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Galán V; Neurology Department, Hospital Universitario de Toledo, Toledo, Spain., de Antonio LAR; Neurology Department, Hospital Universitario de Fuenlabrada, Madrid, Spain., Romero C; Neurology Department, Hospital Universitario de Albacete, Albacete, Spain., García-Rodríguez R; Neurology Department, Centro Médico de Asturias, Oviedo, Spain., Cano-Orgaz AT; Neurology Department, Hospital de Mataró, Mataró, Spain., Sánchez-Menoyo JL; Neurology Department, Hospital Universitario de Galdakao Usansolo, Galdakao (Bizkaia), Spain., Pérez-Ruiz D; Neurology Department, Hospital Comarcal del Bierzo, Ponferrada, Spain., Gutiérrez-Martin F; Neurology Department, Hospital Río Carrión, Palencia, Spain., Hernández-Echevarría L; Neurology Department, Complejo Asistencial Universitario de León, León, Spain., Meca-Lallana V; Neurology Department, Hospital Universitario de La Princesa, Calle de Diego de León, 62, 28006, Madrid, Spain.

Publikováno v: Clinical drug investigation [Clin Drug Investig] 2024 Nov; Vol. 44 (11), pp. 829-838. Date of Electronic Publication: 2024 Oct 28.

[XVI Post-ECTRIMS Meeting: review of the new developments presented at the 2023 ECTRIMS Congress (II)].

Autor: Fernández O; Universidad de Málaga, Málaga, España.; Instituto de Investigación Biomédica de Málaga. IBIMA, Málaga, España.; Hospital Universitario Regional de Málaga, Málaga, España., Montalbán X; Hospital Universitari Vall d'Hebron-CEMCAT, Barcelona, España., Agüera E; Hospital Reina Sofía, 14004 Córdoba, España., Aladro Y; Hospital Universitario de Getafe, 28905 Getafe, España., Alonso A; Hospital Universitario Regional de Málaga, Málaga, España., Arroyo R; Hospital Universitario Quirónsalud, Madrid, España., Brieva L; Hospital Universitari Arnau de Vilanova-Universitat de Lleida, Lleida, España., Calles C; Hospital Universitario Son Espases, Palma de Mallorca, España., Costa-Frossard L; Hospital Universitario Ramón y Cajal, Madrid, España., Eichau S; Hospital Universitario Virgen Macarena, 41003 Sevilla, España., García-Domínguez JM; Hospital Universitario Gregorio Marañón, Madrid, España., Hernández MA; Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España., Landete L; Hospital Universitario Doctor Peset, Valencia, España., Llaneza M; Hospital Universitario Central de Asturias, Oviedo, España., Llufriu S; Hospital Clínic de Barcelona-IDIBAPS, Barcelona, España., Meca-Lallana JE; Hospital Universitario Virgen de la Arrixaca., Murcia, España.; Universidad Católica San Antonio, Murcia, España., Meca-Lallana V; Hospital Clínico Universitario La Princesa, Madrid, España., Moral E; Complejo Hospitalario Universitario Moisés Broggi, Sant Joan Despí, España., Prieto JM; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, España., Ramió-Torrentà L; Hospital Universitari Josep Trueta, 17007 Girona, España.; Universitat de Girona, Girona, España.; Hospital de Santa Caterina, Girona, España.; IDIBGI, Girona, España., Téllez N; Hospital Clínico Universitario de Valladolid, Valladolid, España., Romero-Pinel L; Hospital Universitari de Bellvitge-IDIBELL, L´Hospitalet de Ll., España., Vilaseca A; Hospital Universitari Vall d'Hebron-CEMCAT, Barcelona, España., Rodríguez-Antigüedad A; Hospital Universitario Cruces, Barakaldo, España.

Publikováno v: Revista de neurologia [Rev Neurol] 2024 Jul 16; Vol. 79 (2), pp. 51-66.

Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.

Autor: Fissolo N; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain., Benkert P; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Sastre-Garriga J; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain., Mongay-Ochoa N; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain., Vilaseca-Jolonch A; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain., Llufriu S; Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Blanco Y; Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Hegen H; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Berek K; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Perez-Miralles F; Neuroimmunology Unit, València University and Polytechnic Hospital La Fe, Valencia, Spain., Rejdak K; Department of Neurology, Medical University of Lublin, Lublin, Poland., Villar LM; Departments of Neurology and Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal deInvestigacion Sanitaria (IRYCIS), Madrid, Spain., Monreal E; Department of Neurology, Hospital Universitario Ramón y Cajal, REEM, IRYCIS, Universidad de Alcalá, Madrid, Spain., Alvarez-Lafuente R; Environmental Factors in Degenerative Diseases Research Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico SanCarlos (IdISSC), Madrid, Spain., Soylu OK; Department of Neurology, Ulm University, Ulm, Germany., Abdelhak A; Department of Neurology, Ulm University, Ulm, Germany.; Department of Neurology, Division of Neuroinflammation and Glial Biology, University of California San Francisco, San Francisco, California, USA., Bachhuber F; Department of Neurology, Ulm University, Ulm, Germany., Tumani H; Department of Neurology, Ulm University, Ulm, Germany., Martínez-Yélamos S; Neurology Department, Multiple Sclerosis Unit, Hospital Universitari deBellvitge-IDIBELL, Universitat de Barcelona, Barcelona, Spain., Sánchez-López AJ; Neuroimmunology Unit, Puerta de Hierro-Segovia de Arana Health Research Institute, Madrid, Spain.; Biobank, Puerta de Hierro-Segovia de Arana Health Research Institute, Madrid, Spain., García-Merino A; Neuroimmunology Unit, Puerta de Hierro-Segovia de Arana Health Research Institute, Madrid, Spain., Gutiérrez L; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain., Castillo-Trivino T; Neurology Department, Donostia University Hospital, San Sebastian, Spain., Lycke J; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Rosenstein I; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Furlan R; Clinical Neuroimmunology Unit, Division of Neuroscience, Institute of Experimental Neurology, IRCCS Ospedale San Raffaele, Milan, Italy., Filippi M; Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milano, Italy.; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Università Vita Salute San Raffaele, Milano, Italy., Téllez N; Neurology Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Ramió-Torrentà L; Girona Neuroimmunology and Multiple Sclerosis Unit, Neurology Department,Hospital Universitari Dr. Josep Trueta and Hospital Santa Caterina.Neurodegeneration and Neuroinflammation research group (IDIBGI). Department of Medical Sciences, University of Girona, Girona, Spain., Lünemann JD; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Munster, Germany., Wiendl H; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Munster, Germany., Eichau S; Multiple Sclerosis Unit, Neurology Service, Hospital Universitario Virgen Macarena, Sevilla, Spain., Khalil M; Department of Neurology, Medical University of Graz, Graz, Austria., Kuhle J; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Montalban X; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain., Comabella M; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain manuel.comabella@vhir.org.

Publikováno v: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2024 Apr 12; Vol. 95 (5), pp. 410-418. Date of Electronic Publication: 2024 Apr 12.

Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.

Autor: Meca-Lallana JE; Multiple Sclerosis CSUR and Clinical Neuroimmunology Unit, Neurology Department, Hospital Clínico Universitario Virgen de la Arrixaca (IMIB-Arrixaca)/Clinical Neuroimmunology and Multiple Sclerosis Cathedra, UCAM, Universidad Católica San Antonio, Murcia, Spain. pmecal@gmail.com., Prieto González JM; Neurology Service, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain., Caminero Rodríguez AB; Neurology Service, Complejo Asistencial de Ávila, Ávila, Spain., Olascoaga Urtaza J; Multiple Sclerosis Unit, Hospital Universitario Donostia, Donostia-San Sebastián, Spain., Alonso AM; Neurology Service, Hospital Regional Universitario Málaga, Málaga, Spain., Durán Ferreras E; Neurology Service, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Espinosa R; Neurology Unit, Hospital Universitario Jerez de La Frontera, Cádiz, Spain., Dotor J; Neurology Service, Multiple Sclerosis Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain., Romera M; Neurology Service, Hospital Universitario Virgen de Valme, Sevilla, Spain., Ares Luque A; Neurology Service, Hospital Universitario de León, León, Spain., Pérez Ruiz D; Neurology Unit, Hospital El Bierzo, Ponferrada, Spain., Calles C; Neurology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Hernández MA; Neurology Service, Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain., Hervás García M; Neurology Service, Hospital Insular Universitario de Gran Canaria, Las Palmas de Gran Canaria, Spain., Mendoza Rodríguez A; Neurology Service, Complejo Asistencial de Segovia, Segovia, Spain., Berdei Montero Y; Neurology Service, Hospital Universitario de Salamanca, Salamanca, Spain., Téllez N; Neurology Service, Hospital Clínico Universitario Valladolid, Valladolid, Spain., Herrera Varó N; Neurology Service Hospital Universitario de Burgos, Burgos, Spain., Sotoca J; Neurology Department, Hospital Mútua Terrassa, Barcelona, Spain., Presas-Rodríguez S; MS-Neuroimmunology Unit, Department of Neurosciences, Hospital Germans Trias i Pujol, Badalona, Spain., Querol Gutierrez LA; Neuromuscular Diseases Unit-Autoimmune Neurology-Neuromuscular Lab, Neurology Department-Hospital de la Santa Creu i Sant Pau, Institut de Recerca Biomèdica Sant Pau, Barcelona, Spain., Hervás Pujol M; Neurology Service, Hospital Parc Taulí de Sabadell, Sabadell, Spain., Batlle Nadal J; Neurology Service, Hospital Sant Pau i Santa Tecla, Tarragona, Spain., Martín Ozaeta G; Neurology Service, Hospital Verge de la Cinta, Tortosa, Spain., Gubieras Lillo L; Neurology Service, Hospital Sant Joan Despí Moisès Broggi, Barcelona, Spain., Martínez Yélamos S; Multiple Sclerosis Unit, Hospital Universitario de Bellvitge, Institut Català de la Salut, Barcelona, Spain., Ramió-Torrentà L; Neurology Department, Hospital Universitario Dr. Josep Trueta i Santa Caterina, Girona, Spain., Mallada Frechin J; Neurology Service, Hospital General Universitario de Elda, Alicante, Spain., Belenguer Benavides A; Neurology Service, Hospital General Universitari de Castelló, Castelló, Spain., Gascón-Giménez F; Multiple Sclerosis Unit, Hospital Clínico Universitario Valencia, Valencia, Spain., Casanova B; Neuroimmunology Unit, Hospital Universitari I Politècnic La Fe, Valencia, Spain., Landete Pascual L; Neurology Department, Hospital Universitario Dr. Peset, Valencia, Spain., Berenguer L; Neurology Service, Hospital Marina Baixa, Valencia, Spain., Navarro L; Neurology Department, Hospital General Universitario de Elche, Alicante, Spain., Gómez Gutierrez M; Neurology Service, Hospital Universitario de Cáceres, Cáceres, Spain., Durán C; Neurology Service, Hospital Universitario Infanta Cristina, Badajoz, Spain., Rodríguez Regal A; Neurology Service, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain., Álvarez E; Neurology Service, Hospital Álvaro Cunqueiro, Vigo, Pontevedra, Spain., García-Estévez DA; Neurology Service, Complejo Hospitalario Universitario de Ourense, Ourense, Spain., López Real AM; Neurology Service, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., Llaneza González MA; Neurology Department, Hospital Central Universitario de Asturias, Oviedo, Spain., Marzo Sola ME; Neurology Service, Hospital San Pedro, Logroño, La Rioja, Spain., Sánchez-Menoyo JL; Neurology Department, Hospital Universitario Galdakao-Usansolo, Bizkaia, Spain., Oterino A; Neurology Service, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Villaverde González R; Neurology Service, Hospital Universitario José María Morales Meseguer, Murcia, Spain., Castillo-Triviño T; Neurology Service, Hospital Universitario de Donostia, Gipuzkoa, Spain., Álvarez de Arcaya A; Neurology Department, Hospital Universitario Araba, Vitoria-Gasteiz, Spain., Llarena C; Neurology Service, Hospital Universitario Basurto, Bilbao, Spain.

Publikováno v: Neurology and therapy [Neurol Ther] 2023 Dec; Vol. 12 (6), pp. 2177-2193. Date of Electronic Publication: 2023 Oct 20.

[Nicolau syndrome due to self-injectable drugs in multiple sclerosis].

Autor: Neri MJ; Hospital Clínico Universitario de Valladolid, Valladolid, España., Mulero P; Hospital Clínico Universitario de Valladolid, Valladolid, España., Téllez N; Hospital Clínico Universitario de Valladolid, Valladolid, España.

Publikováno v: Revista de neurologia [Rev Neurol] 2023 Aug 01; Vol. 77 (3), pp. 75-78.